Owing to the emerging applications of medical animation, several market players have shown keen interest in this field, indicating a promising future of this technology. Recently, VR Health Champions (Co-Funded by the European Union) initiated €7.8 million project to accelerate the adoption of extended reality (XR) technologies in healthcare across European region. This three-year project is aiming to fast-track the advancements of VR / AR applications in medical diagnostics, therapies and sur...

The metagenomic sequencing market size is estimated to grow from USD 2.20 billion in 2024 to USD 2.55 billion in 2025 and USD 8.63 billion by 2035, representing a CAGR of 13.0% during the forecast period. Based on the type of offering, the global market is segmented into reagents and consumables, instruments, and sequencing & data analytics services. According to metagenomic sequencing market forecast, presently reagents and consumables hold the highest share of the market. This can be attribute...

The global iron deficiency anemia treatment market, valued at USD 4.66 billion in 2024, is projected to reach USD 5.09 billion in 2025 and USD 10.71 billion by 2035, representing a CAGR of 7.7% during the forecast period. According to our iron deficiency anemia treatment market report, presently parenteral iron therapy segment accounts for the largest share (60%) of the market.

The global teleradiology market size, valued at USD 12.46 billion in 2024, is projected to reach USD 15.36 billion in 2025 and USD 81.01 billion by 2035, representing a CAGR of 18.1% during the forecast period. Driven by the ongoing trajectory towards teleradiology, several industrial players are focusing on innovations to accelerate the adoption across the globe.

The global sickle cell disease market size, valued at USD 3.02 billion in 2024, is projected to reach USD 3.63 billion in 2025 and USD 16.01 billion by 2035, representing a CAGR of 16.0% during the forecast period. Driven by the ongoing initiatives, we believe that the sickle cell disease treatment market is expected to grow at a steady rate during the forecast period, offering lucrative opportunities to drug developers for investments.

The global mental health apps market size, valued at USD 7.22 billion in 2024, is projected to reach USD 8.54 billion in 2025 and USD 33.54 billion by 2035, representing a CAGR of 14.7% during the forecast period. Owing to ongoing demand, several industrial players and government organizations are focusing on strategic initiatives, followed by latest app launch, customizing therapies sessions and advanced features for managing mental well-being.

The global behavioral healthcare software market, valued at USD 3.37 billion in 2024, is projected to reach USD 3.92 billion in 2025 and USD 13.59 billion by 2035, representing a CAGR of 13.2% during the forecast period. Driven by the ongoing challenges, behavioral health software emerged as an invaluable solution to improve patient outcomes and streamline administrative workflow.

The global bioprocess analyzers market, valued at USD 2.58 billion in 2024, is projected to reach USD 2.88 billion in 2025 and USD 7.23 billion by 2035, representing a CAGR of 9.6% during the forecast period. Owing to the increasing initiatives by industrial players, we believe that bioprocess analyzer market is expected to grow at a steady rate during the forecast period.

The global software as a medical device market, valued at USD 29.60 billion in 2024, is projected to reach USD 36.92 billion in 2025 and USD 210.74 billion by 2035, representing a CAGR of 19.0% during the forecast period. Driven by the growing shift towards digital healthcare solutions, software as a medical device emerged as an unprecedented tool to facilitate virtual consultation for managing diseases remotely. Additionally, the growing shift towards personalized therapeutics to mitigate the g...

The global astaxanthin market size, valued at USD 2.52 billion in 2024, is projected to reach USD 2.83 billion in 2025 and USD 7.57 billion by 2035, representing a CAGR of 10.3% during the forecast period. According to our astaxanthin market report, presently North America accounts for the highest share of the market.

The global single cell multi-omics market, valued at USD 3.18 billion in 2024, is expected to reach USD 3.93 billion in 2025 and USD 21.13 billion by 2035, representing a higher CAGR of 18.3% during the forecast period. Based on the type of product, the global market is segmented into instruments and consumables. According to our single cell multi-omics market analysis, the instruments segment accounts for the largest market share. It is worth mentioning here that the trend of dominance will con...

The global disposable medical sensors market, valued at USD 12.24 billion in 2024, is projected to reach USD 14.98 billion in 2025 and USD 75.08 billion by 2035, representing a CAGR of 17.5% during the forecast period. Owing to the continuous innovation in this field, we believe that the disposable medical device sensors market is likely to grow at a steady rate during the forecast period.

The water treatment market size is projected to grow from USD 334.6 billion in 2026 to USD 809.5 billion by 2040, representing a CAGR of 6.51%, during the forecast period till 2040.The water treatment market is emerging as a critical component in the global shift towards modern water treatment innovation and digital advancement to reach higher safe water availability. Innovations, including advanced membrane technologies, which enhance contaminant removal while reducing energy consumption. Nota...

The global congenital heart defect devices market, valued at USD 2.72 billion in 2024, is projected to reach USD 2.91 billion in 2025 and USD 5.07 billion by 2035, representing a CAGR of 5.7% during the forecast period. Driven by the ongoing demand, several industry players are aiming to develop advanced congenital heart defect devices that aid in treating patients with congenital heart defect devices.

The nutraceutical product testing market size is estimated to be USD 2.93 billion in 2025 and is projected to reach USD 7.33 billion by 2035. The market is anticipated to grow at a CAGR of 9.6%, during the forecast period, till 2035. In 2024, around 2 million new cancer cases and 611,720 deaths due to cancer have been reported in the US, with a significant rise in cancer rate predicted in the coming years. Currently, the analytical testing segment captures the maximum share (32%) in the overall...

The global epigenomics market, valued at USD 1.98 billion in 2024, is projected to reach USD 2.32 billion in 2025 and USD 8.49 billion by 2035, representing a CAGR of 13.8% during the forecast period. With growing usage across healthcare industry, various industrial players are focusing on the development of advanced products, instruments, and services.

The global breath analyzers market, valued at USD 3.34 billion in 2024, is projected to reach USD 3.96 billion in 2025 and USD 15.95 billion by 2035, representing a CAGR of 15.0% during the forecast period. Presently, fuel cell technology segment accounts for the largest breath analyzers market share (35%).

The global RNAi drug delivery market, valued at USD 103.23 billion in 2024, is projected to reach USD 134.0 billion in 2025 and USD 818.45 billion by 2035, representing a CAGR of 19.8% during the forecast period. According to our RNAi drug delivery market report, presently siRNA segment accounts for the largest share of the market.

The global cell cytometry market size, valued at USD 1.99 billion in 2025, is projected to reach USD 2.18 billion in 2026 and USD 5.27 billion by 2035, representing a CAGR of 10.3% during the forecast period. Cell cytometry is an advanced analytical technique that helps in the analysis and characterization of cells. This technology has recently gained momentum across healthcare and pharmaceutical industry for the identification of biomarkers and evaluating the relationship between pharmacodynami...

The global hair transplant market size is valued at USD 8.01 billion in 2024 and is estimated to reach USD 15.65 billion by 2035, representing a CAGR of 6.28%, during the forecast period. It is important to highlight here that in March 2023, Venus Concept successfully launched the latest generation of ARTAS iX for hair transplantation, which is integrated with several technologies, such as machine learning, artificial intelligence and surgical robots. In addition to technological innovations, se...